Triglyceride-Glucose Index and Major Adverse Cardiovascular Events in Diabetic and Nondiabetic Patients: A Systematic Review and Meta-Analysis
Diabetes Technology and Obesity Medicine · 2025
DOI: 10.1089/dtom.2025.0002 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Diabetes Technology and Obesity Medicine, 2025. Verfasst von Asma Mousavi und 6 weiteren Autor:innen. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 65 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Insulin resistance (IR) is increasingly recognized as a significant risk factor for adverse cardiovascular outcomes. The triglyceride-glucose index (TyG) has emerged as a potential proxy for IR, but its role as a predictor of major adverse cardiovascular events (MACE) in diabetic and nondiabetic populations remains unclear. This systematic review and meta-analysis evaluated the association between the TyG index and MACE outcomes. A comprehensive literature search of PubMed, Embase, Scopus, and Web of Science was conducted for studies published up to August 2024. Twenty-five studies involving 105,755 participants were included. Hazard ratios (HRs) and 95% confidence intervals (CIs) were calculated using a random-effects model, treating TyG as both a continuous variable and by comparing the highest versus lowest TyG groups. In diabetic patients, the pooled HR for MACE when comparing the highest and lowest TyG groups was 1.89 (95% CI: 1.42–2.53, P < 0.01), and a 1-unit increase in the TyG index was associated with a 93% higher MACE risk (HR 1.93, 95% CI: 1.36–2.73, P < 0.01). Similar trends were observed for MACE components, including cardiovascular mortality, myocardial infarction, stroke, and revascularization. Among nondiabetic patients, the pooled HR for MACE was 1.78 (95% CI: 1.24–2.56, P < 0.01), with a 1-unit TyG increase linked to a 52% higher MACE risk (HR 1.52, 95% CI: 1.08–2.15, P = 0.02). Component analysis further supported these findings. This study demonstrates that the TyG index is a significant predictor of MACE risk in both diabetic and nondiabetic populations, underscoring its potential clinical utility for early cardiovascular risk stratification. Further research is needed to confirm these findings and explore the practical implications of TyG in routine clinical care.
Zitieren
APA
Mousavi, A., Radkhah, H., Shad, A. N., Akhlaghipour, I., Azarboo, A., Forutan, H., & Shojaei, S. (2025). Triglyceride-Glucose Index and Major Adverse Cardiovascular Events in Diabetic and Nondiabetic Patients: A Systematic Review and Meta-Analysis. Diabetes Technology and Obesity Medicine. https://doi.org/10.1089/dtom.2025.0002
Vancouver
Mousavi A, Radkhah H, Shad AN, Akhlaghipour I, Azarboo A, Forutan H, et al. Triglyceride-Glucose Index and Major Adverse Cardiovascular Events in Diabetic and Nondiabetic Patients: A Systematic Review and Meta-Analysis. Diabetes Technology and Obesity Medicine. 2025. doi:10.1089/dtom.2025.0002
BibTeX
@article{Mousavi2025,
author = {Mousavi, Asma and Radkhah, Hanieh and Shad, Arya Nasimi and Akhlaghipour, Iman and Azarboo, Alireza and Forutan, Hooman and Shojaei, Shayan},
title = {Triglyceride-Glucose Index and Major Adverse Cardiovascular Events in Diabetic and Nondiabetic Patients: A Systematic Review and Meta-Analysis},
journal = {Diabetes Technology and Obesity Medicine},
year = {2025},
doi = {10.1089/dtom.2025.0002}
}
EUVIMED